Quick Answer
Envoy Medical, Inc. reported Operating Income Loss of -$22.27 million for the year ending 2025.
- Envoy Medical, Inc. showed a decrease of -15.7% in Operating Income Loss from 2024 to 2025.
- This data is from Envoy Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Envoy Medical, Inc.'s Operating Income Loss has declined by 3,176,790.2%.
- Historical annual values: Fiscal year 2025: -$22.27 million | Fiscal year 2024: -$19.26 million | Fiscal year 2023: -$18.36 million | Fiscal year 2022: -$8.71 million | Fiscal year 2021: -$5.20 million | Fiscal year 2020: -$701.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: